| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 09/10/2009 | US20090227030 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor |
| 09/10/2009 | US20090226987 Desaturase Genes, Enzymes Encoded Thereby, and Uses Thereof |
| 09/10/2009 | US20090226460 Compositions and methods for the treatment of disease |
| 09/10/2009 | US20090226430 Recombinant anti-cd4 antibodies for human therapy |
| 09/10/2009 | US20090226428 Anti-inflammatory dab |
| 09/10/2009 | US20090226422 Chemical Inhibitors of Inhibitors of Differentiation |
| 09/09/2009 | EP2098515A1 Substituted carbinol compound |
| 09/09/2009 | EP2098248A1 Combination of anticholinergics, glucocorticoids and beta2-agonists for the treatment of inflammatory diseases |
| 09/09/2009 | EP2098245A1 Use of cholinesterase for manufacturing an anti-tachykinins medicament |
| 09/09/2009 | EP2097529A1 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof |
| 09/09/2009 | EP2097407A1 Pyrazole analogs |
| 09/09/2009 | EP2097406A1 Hydantoin derivatives used as mmp inhibitors |
| 09/09/2009 | EP2097384A1 Indozalyl sulphonamide derivatives useful as glucocorticoid modulators |
| 09/09/2009 | EP2097371A2 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity |
| 09/09/2009 | EP2097079A2 Modulation of prostaglandin/cyclooxygenase metabolic pathways |
| 09/09/2009 | EP1856045B1 1-acetic acid-indole derivatives with pgd2 antagonist activity |
| 09/09/2009 | EP1539753B1 Pyrazolo(3,4-b)pyridine compounds, and their use as phosphodiesterase inhibitors |
| 09/09/2009 | EP1509621B1 Diagnostic of alzheimer's disease by analysis of il-10 gene polymorphisms |
| 09/09/2009 | EP1474150B1 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of cardiac insufficiency |
| 09/09/2009 | EP1397355B1 Pyridyl cyanoguanidine compounds |
| 09/09/2009 | EP1371370B1 Drugs containing reduced vitamin b2 |
| 09/09/2009 | CN101524518A Chinese medicinal composition for treating asthma and preparation method thereof |
| 09/09/2009 | CN101524517A Compound Chinese and western medicine for treating upper respiratory tract infection |
| 09/09/2009 | CN101524497A Chinese medicinal preparation for treating pharyngitis |
| 09/09/2009 | CN101524493A Multifunctional Chinese medicine honeyed pill |
| 09/09/2009 | CN101524479A Medicine for curing avian infectious bronchitis |
| 09/09/2009 | CN101524478A Medicine for relieving asthma and diminishing inflammation and preparation method thereof |
| 09/09/2009 | CN101524463A Chinese medicinal composition for treating pulmonitis and preparation method thereof |
| 09/09/2009 | CN101524454A Preparation process for Chinese yam extract |
| 09/09/2009 | CN101524443A Dripping pill for relieving cough and asthma and preparation method thereof |
| 09/09/2009 | CN101524436A Chinese medicinal composition for treating lung cancer |
| 09/09/2009 | CN101524434A Antibacterial cream for treating rhinitis and preparation method thereof |
| 09/09/2009 | CN101524424A Application of Qingfei Xiaoyan pill in medication for treating chronic obstructive pulmonary diseases |
| 09/09/2009 | CN101524420A Chinese herbal medicament mixture for treating acute and chronic pharyngitis |
| 09/09/2009 | CN101524404A Enteric sustained and controlled release capsule |
| 09/09/2009 | CN101524398A Medical application of licorice flavonoids |
| 09/09/2009 | CN101524397A Licorice flavonoids antitussive and application thereof |
| 09/09/2009 | CN101524393A Preparation method of gypenoside |
| 09/09/2009 | CN101524388A Pharmaceutical composition for curing rhinitis and preparation method thereof |
| 09/09/2009 | CN101524380A Preparation process for folium ginkgo extract |
| 09/09/2009 | CN101524377A Composite of wall-breaking lucidum spore powder and cyclodextrin and preparation method thereof |
| 09/09/2009 | CN101524375A Wet-process wall breaking method of lucidum spore powder |
| 09/09/2009 | CN101524372A Medicament for treating dermatitis, rhinitis, hemorrhoids, acne and other diseases and production method thereof |
| 09/09/2009 | CN101524368A Gel Bingpeng powder film agent |
| 09/09/2009 | CN101524362A Application of nucleic acid with CpG motif for preparing anti-fibrotic drug |
| 09/09/2009 | CN101524325A Compound menthol microemulsion and preparation for nose |
| 09/09/2009 | CN101524225A Production method of silk quilt for treating tracheitis and bronchitis |
| 09/09/2009 | CN100537571C Imidazo[1,2-a]pyrazin-8-ylamines, method of making and method of use thereof |
| 09/09/2009 | CN100537546C Novel alkansulfonamides as endothelin antagonists |
| 09/09/2009 | CN100536839C Urea derivatives as integrin alpha 4 antagonists |
| 09/09/2009 | CN100536830C Medication for treating cough and gasp |
| 09/08/2009 | US7585947 IL-7 drug substance, composition, preparation and uses |
| 09/08/2009 | US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder |
| 09/08/2009 | US7585867 Substituted thiazolo[4,5-d]pyrimidin-2(3H)-one |
| 09/08/2009 | US7585520 Compositions containing both sedative and non-sedative antihistamines and sleep aids |
| 09/08/2009 | US7585507 Nucleic acid molecules and polypeptides for immune modulation |
| 09/08/2009 | CA2468833C (20s)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| 09/08/2009 | CA2442210C Aryl oxime-piperazines useful as ccr5 antagonists |
| 09/08/2009 | CA2342739C Azetidine derivatives, preparation and medicines containing them |
| 09/08/2009 | CA2290745C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 09/03/2009 | WO2009107767A1 Novel bicyclic pyrimidine derivative having antagonistic activity on h4 receptor |
| 09/03/2009 | WO2009107736A1 Fibrosis inhibitor |
| 09/03/2009 | WO2009107380A1 Anti-allergic agent |
| 09/03/2009 | WO2009106708A2 Azetidine derivatives, their preparation and their application in therapy |
| 09/03/2009 | WO2009106531A1 Pyrrolopyrimidinecarboxamides |
| 09/03/2009 | WO2009106419A1 New macrolides and their use |
| 09/03/2009 | WO2009106368A1 Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases |
| 09/03/2009 | WO2009106351A1 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the b2 adrenergic receptor |
| 09/03/2009 | WO2009086470A3 Aerosolized nitrite and nitric oxide - donating compounds and uses thereof |
| 09/03/2009 | WO2009073683A3 Methods of treating copd |
| 09/03/2009 | WO2009061447A9 Treatment of premature birth complications |
| 09/03/2009 | WO2009049742A3 Use of melanotrophin-potentiating factor as a therapeutic agent |
| 09/03/2009 | WO2009046829A3 Casoxin d as a therapeutic agent |
| 09/03/2009 | WO2009043480A3 Use of leptin (22-56 ) as a therapeutic agent |
| 09/03/2009 | WO2009043469A3 Use of pneumadin as a therapeutic agent |
| 09/03/2009 | WO2009040018A3 Use of a peptide as a therapeutic agent |
| 09/03/2009 | WO2009040017A3 Use of a peptide as a therapeutic agent |
| 09/03/2009 | WO2009039993A3 Use of melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infection |
| 09/03/2009 | WO2009039992A3 Use of band 3 protein (824-829) and/or melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infection |
| 09/03/2009 | WO2009039988A3 Use of a fibrinogen receptor antagonist and/or follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumonia infection |
| 09/03/2009 | WO2009033805A3 Use of somatostatin-14 as a therapeutic agent |
| 09/03/2009 | WO2009033802A3 Antide as a therapeutic agent |
| 09/03/2009 | WO2009033801A3 Syndyphalin alone or in combination with antide as a therapeutic agent |
| 09/03/2009 | WO2009033755A3 Use of l-carnosine as a therapeutic agent |
| 09/03/2009 | WO2009033741A3 Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s) |
| 09/03/2009 | WO2009033731A3 Use of a laminin peptide as a therapeutic agent |
| 09/03/2009 | WO2009033723A3 Use of aip2 as a therapeutic agent |
| 09/03/2009 | WO2009033714A3 Use of a peptide as a therapeutic agent |
| 09/03/2009 | WO2009033692A3 Use of the peptides fibrinopeptide a and pyx-i as a therapeutic agents |
| 09/03/2009 | WO2009033665A3 Use of a rgd-peptide and/or parathyroid hormone (1-34 ) as anti-hiv agent |
| 09/03/2009 | WO2009033656A3 Use of follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumoniae infection |
| 09/03/2009 | WO2009030492A3 Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion |
| 09/03/2009 | US20090221821 Adenosine receptor antagonists and methods of making and using the same |
| 09/03/2009 | US20090221712 Mandelic hydrazides |
| 09/03/2009 | US20090221686 Modulation of the Transcription of Pro-Inflammatory Gene Products |
| 09/03/2009 | US20090221641 Diaza-spiro--nonane derivatives as neurokinin (nk1) antagonists |
| 09/03/2009 | US20090221632 Bicyclo-Pyrazoles and Pharmaceutical Compositions Comprising Them |
| 09/03/2009 | US20090221626 Aerosol formulation for inhalation containing an anticholinergic agent |
| 09/03/2009 | US20090221604 Thiazole Compounds and Their Use as PGD2 Antagonists |
| 09/03/2009 | US20090221602 Processes for preparing substituted pyrimidines |